Showing results 1 to 20 of 57
next >
| Issue Date | Title | Author(s) |
| 2023-07-03 | Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study. | Yenson, VM; Amgarth-Duff, I; Brown, L; Caperchione, CM; Clark, K; Cross, A; Good, P; Landers, A; Luckett, T; Philip, J; Steer, C; Vardy, JL; Wong, AK; Agar, MR |
| 2023-06 | Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials. | Gurgenci, T; Hardy, J; Olson, R; Huggett, G; Foster, K; Good, P |
| 2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
| 2023-02 | 'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer. | Olson, RE; Smith, A; Good, P; Dudley, M; Gurgenci, T; Hardy, J |
| 2022-10-19 | Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life. | Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM |
| 2022-09-13 | Pain management in advanced cancer: physical activity as an outcome - accelerometer feasibility study. | Lord, S; Good, P; Mielke, GI |
| 2022-09-05 | Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer. | Olson, RE; Smith, A; Huggett, G; Good, P; Dudley, M; Hardy, J |
| 2022-06-14 | Research agenda for medical cannabis in palliative care. | Gurgenci, T; Hardy, J; Good, P |
| 2022-06 | Impact of expected parental death on the health of adolescent and young adult children: A systematic review of the literature. | Jessop, M; Fischer, A; Good, P |
| 2022-04 | Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer? | Lord, S; Hardy, J; Good, P |
| 2022-04 | Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer. | Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM |
| 2022-03 | Hypertonic packs to reverse blindness caused by facial lymphoedema in the setting of head and neck cancer - A case report. | Gurgenci, T; Cree, R; Jessop, M; Lomas, J; Good, P |
| 2022-01-01 | Evaluation of a nurse practitioner role within a specialist palliative care service in Australia | Fischer, A; May, A; Lancaster, M; Alexander, K; Good, P |
| 2022-01-01 | Survival following palliative percutaneous nephrostomy tube insertion in patients with malignant ureteric obstruction: Validating a prognostic model | Gunawan, B; Foster, K; Hardy, J; Good, P |
| 2021-10-09 | Hopeful dying? The meanings and practice of hope in palliative care family meetings. | Kirby, E; Broom, A; MacArtney, J; Lewis, S; Good, P |
| 2021-03 | Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer. | Hardy, J; Haywood, A; Rickett, K; Sallnow, L; Good, P |
| 2021-01-01 | Emotionally reflexive labour in end-of-life communication. | Olson, RE; Smith, A; Good, P; Neate, E; Hughes, C; Hardy, J |
| 2020 | Regular dosing compared with as-needed dosing of opioids for management of chronic cancer pain: systematic review and meta-analysis. | Edler-Buggy, S; Birtwistle, J; ElMokhallalati, Y; Kindl, K; Good, P; Bennett, MI |
| 2019-12-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) | Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J |
| 2019-12-01 | Quality use of medicines: Oral corticosteroids in advanced cancer | Pinkerton, E; Good, P; Kindl, K; Richard, R; Fischer, A; Hardy, JR |
